IMRX Stock Analysis: Buy, Sell, or Hold?
IMRX - Immuneering Corporation Class A Common Stock
$4.19
0.00 (0.00%)
▲
5d:
+6.62%
30d:
-18.48%
90d:
-15.52%
HOLD
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When IMRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IMRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IMRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IMRX is currently trading at $4.19, which is considered oversold relative to its 30-day fair value range of $4.36 to $5.40.
Technical Outlook: Technically, IMRX is in a strong uptrend. Immediate support is located at $3.86, while resistance sits at $4.67.
Market Sentiment: IMRX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $17.00 (+305.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IMRX is in a strong uptrend. Immediate support is located at $3.86, while resistance sits at $4.67.
Market Sentiment: IMRX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $17.00 (+305.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.36 -
$5.40
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 305.7% below Wall St target ($17.00)
Trading Range Analysis
30-Day Trading Range
$4.36 -
$5.40
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.86
Resistance Level
$4.67
Current Trend
Strong Uptrend
Technical data as of
Jun 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.13
Wall Street Target
$17.00
(+305.7%)
Revenue Growth (YoY)
-99.8%
Share & Embed Analysis
Last updated: June 15, 2026 4:12 PM ET
Data refreshes hourly during market hours. Next update: 5:12 PM
Data refreshes hourly during market hours. Next update: 5:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMRX showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Harold Eugene Brakewood
BUY
5250 shares
2026-01-16
Brett Matthew Hall
BUY
2298 shares
2026-01-15
Thomas J Schall
BUY
21645 shares
2026-01-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$439 | 57 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 52 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 67 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$198 | 56 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 50 HOLD |
